Recursion Pharmaceuticals Inc
Ownership
Ownership Structure
Who owns Recursion Pharmaceuticals Inc (RXRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.8% of the shares are freely tradable; institutional investors hold 68.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.05 | 43,192,306 | +11.1 | 03/31/2026 |
| ARK Investment Management LLC | 7.50 | 40,212,769 | +7.8 | 03/31/2026 |
| State Street Corp | 5.31 | 28,490,638 | +12.5 | 03/31/2026 |
| Baillie Gifford & Co Limited. | 4.38 | 23,487,907 | -0.8 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 4.24 | 22,759,100 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.15 | 22,244,387 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 4.34 | 23,296,341 | -1.1 | 08/31/2026 |
| ARK Disruptive Innovation Full Composite | 3.85 | 20,667,375 | -7.9 | 06/30/2026 |
| ARK Innovation ETF | 3.64 | 19,503,944 | -0.9 | 08/31/2026 |
| Scottish Mortgage Ord | 3.39 | 18,174,384 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Borgeson Blake | Director | 6,158,287 | 23,401,491 $ | Sep 1, 2026 | direct |
| Khan Najat | CEO and President | 2,072,890 | 7,876,982 $ | Sep 8, 2026 | direct |
| Taylor Ben R | Chief Financial Officer | 1,071,462 | 4,071,556 $ | Sep 15, 2026 | direct |
| Hallett David | Chief Scientific Officer | 1,043,837 | 3,966,581 $ | Aug 17, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Taylor Ben R | Chief Financial Officer | Other | 5,396 | 3.41 | 18,400 |
| Sep 8, 2026 | Khan Najat | CEO and President | Sell | 22,408 | 3.52 | 78,822 |
| Sep 1, 2026 | Borgeson Blake | Director | Sell | 30,000 | 3.34 | 100,200 |
| Aug 17, 2026 | Khan Najat | CEO and President | Other | 80,498 | 3.16 | 254,374 |
| Aug 17, 2026 | Hallett David | Chief Scientific Officer | Other | 26,657 | 3.16 | 84,236 |
| Aug 17, 2026 | Taylor Ben R | Chief Financial Officer | Other | 25,018 | 3.16 | 79,057 |
| Aug 4, 2026 | Borgeson Blake | Director | Sell | 30,000 | 3.25 | 97,500 |
| Jul 7, 2026 | Borgeson Blake | Director | Sell | 40,000 | 3.96 | 158,500 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.